| Case Number | 8423 |
| Request Date | 08/02/2022 |
| Completion Date | 10/02/2022 |
Details of the Request
Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department for any medical condition, and if possible, for Ulcerative Colitis, with the following biologic drugs:
- Total Gastroenterology Patients
- Ulcerative Colitis Patients
Treatments:
- Adalimumab - Humira
- Adalimumab Biosimilar
- Filgotinib
- Golimumab
- Infliximab - Remicade
- Infliximab Biosimilar
- Ozanimod
- Tofacitinib
- Ustekinumab
- Vedolizumab
Details of the Response
| Treatments | Total Gastroenterology Patients | Ulcerative Colitis Patients |
| Adalimumab - Humira | 18 | 3 |
| Adalimumab Biosimilar | 1 | 0 |
| Filgotinib | 7 | 0 |
| Golimumab | 0 | 0 |
| Infliximab - Remicade | 29 | 6 |
| Infliximab Biosimilar | 1 | 0 |
| Ozanimod | 0 | 0 |
| Tofacitinib | 7 | 7 |
| Ustekinumab | 17 | 3 |
| Vedolizumab | 11 | 7 |



